Browse > Article
http://dx.doi.org/10.3344/kjp.2012.25.1.47

Catheter Obstruction of Intrathecal Drug Administration System -A Case Report-  

Rhee, Seok-Myeon (Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital)
Choi, Eun-Joo (Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital)
Lee, Pyung-Bok (Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital)
Nahm, Francis Sahn-Gun (Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital)
Publication Information
The Korean Journal of Pain / v.25, no.1, 2012 , pp. 47-51 More about this Journal
Abstract
Intrathecal drug administration system (ITDAS) can reduce the side effects while increasing the effectiveness of opioids compared to systemic opioid administration. Therefore, the use of ITDAS has increased in the management of cancer pain and chronic intractable pain. Catheter obstruction is a serious complication of ITDAS. Here, we present a case of catheter obstruction by a mass formed at the side hole and in the lumen. A 37-year-old man suffering from failed back surgery syndrome received an ITDAS implantation, and the ITDAS was refilled with morphine every 3 months. When the patient visited the hospital 18 months after ITDAS implantation for a refill, the amount of delivered morphine sulfate was much less than expected. Movement of the pump rotor was examined with fluoroscopy; however, it was normal. CSF aspiration through the catheter access port was impossible. When the intrathecal catheter was removed, we observed that the side hole and lumen of the catheter was plugged.
Keywords
implantable infusion pump; indwelling catheter; morphine; spinal injection;
Citations & Related Records

Times Cited By SCOPUS : 1
연도 인용수 순위
  • Reference
1 Nahm FS, Kim YC. The intrathecal drug administration system. Korean J Pain 2009; 22: 117-23.
2 Onofrio BM, Yaksh TL, Arnold PG. Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clin Proc 1981; 56: 516-20.
3 Johnston J, Reich S, Bailey A, Sluetz J. Shiley INFUSAID Pump technology. Ann N Y Acad Sci 1988; 531: 57-65.
4 Belverud S, Mogilner A, Schulder M. Intrathecal pumps. Neurotherapeutics 2008; 5: 114-22.
5 Paice JA, Penn RD, Shott S. Intraspinal morphine for chronic pain: a retrospective, multicenter study. J Pain Symptom Manage 1996; 11: 71-80.
6 Deer T, Krames ES, Hassenbusch S, Burton A, Caraway D, Dupen S, et al. Management of intrathecal catheter-tip inflammatory masses: an updated 2007 consensus statement from an expert panel. Neuromodulation 2008; 11: 77-91.
7 North RB, Cutchis PN, Epstein JA, Long DM. Spinal cord compression complicating subarachnoid infusion of morphine: case report and laboratory experience. Neurosurgery 1991; 29: 778-84.
8 Yaksh TL, Hassenbusch S, Burchiel K, Hildebrand KR, Page LM, Coffey RJ. Inflammatory masses associated with intrathecal drug infusion: a review of preclinical evidence and human data. Pain Med 2002; 3: 300-12.
9 Magazine HI, Liu Y, Bilfinger TV, Fricchione GL, Stefano GB. Morphine-induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide. J Immunol 1996; 156: 4845-50.
10 Miele VJ, Price KO, Bloomfield S, Hogg J, Bailes JE. A review of intrathecal morphine therapy related granulomas. Eur J Pain 2006; 10: 251-61.
11 Hassenbusch S, Burchiel K, Coffey RJ, Cousins MJ, Deer T, Hahn MB, et al. Management of intrathecal catheter-tip inflammatory masses: a consensus statement. Pain Med 2002; 3: 313-23.
12 Coffey RJ, Burchiel K. Inflammatory mass lesions associated with intrathecal drug infusion catheters: report and observations on 41 patients. Neurosurgery 2002; 50: 78-86.